Brief: Race Oncology Executes Agreement With Ardena
12/07/2023 02:31
July 12 (Reuters) - Race Oncology Ltd RAC.AX :
* RACE EXECUTES AGREEMENT WITH ARDENA FOR GMP MANUFACTURING
OF
RC220
* INITIAL DEVELOPMENT BUDGET CONTRACTED IS ABOUT US$1M
Source text for Eikon: ID:nASX1hsfWx
Further company coverage: RAC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220